Evogene Ltd. EVGN
NASDAQ
| 06/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -72.52% | -72.48% | -705.85% | -65.69% | 43.27% |
| Total Depreciation and Amortization | -36.45% | -6.45% | -29.71% | 0.30% | 2.16% |
| Total Amortization of Deferred Charges | 1.23% | 1.23% | -2.40% | -- | -- |
| Total Other Non-Cash Items | 121.30% | 133.68% | 69.30% | -208.87% | 105.43% |
| Change in Net Operating Assets | 181.11% | 162.29% | -300.76% | 138.71% | -248.39% |
| Cash from Operations | 55.60% | 55.60% | -13.62% | -37.25% | 15.20% |
| Capital Expenditure | 99.17% | 98.35% | 62.42% | 60.19% | -74.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.49% | 57.53% | -125.59% | -112.95% | 149.64% |
| Cash from Investing | 59.55% | 59.55% | -127.92% | -116.08% | 146.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 43.84% | 6.16% | 52.90% | -0.47% | -1.93% |
| Issuance of Common Stock | -- | -- | -- | -99.44% | 11,764.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.00% | 123.08% | -112.50% | 134.48% | -100.55% |
| Cash from Financing | 2,709.43% | 2,709.43% | 22.82% | -101.88% | -25.35% |
| Foreign Exchange rate Adjustments | 325.00% | 325.00% | -185.71% | 453.57% | 87.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.68% | 110.68% | -295.93% | -192.41% | 356.52% |